BOVILIS Vista 5 VL5 CFP (Canada)

Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Vaccine, Modified Live Virus, Campylobacter Fetus-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin

Cattle Vaccine

BOVILIS Vista 5 VL5 CFP Indications

This product has been shown effective for the vaccination of healthy cattle 6 months of age or older against respiratory disease and abortion due to infectious bovine rhinotracheitis (IBR), respiratory disease and fetal infection, including persistently infected calves due to bovine virus diarrhea virus (BVD) Types 1 & 2, bovine respiratory syncytial virus (BRSV) and parainfluenza3 virus (PI3), reproductive disease caused by Campylobacter fetus and leptospirosis (caused by Leptospira canicola, L. grippotyphosa, L. hardjo - including the L. borgpetersenii serovar hardjo bovis, L. icterohaemorrhagiae, and L. Pomona). Reproductive duration of immunity has been shown to be at least 217 days for IBR and at least 206 days for BVD (Types 1 & 2). Respiratory duration of immunity has been demonstrated to be at least 182 days for IBR, and at least 206 days for BVD Type 1 and at least 200 days for BVD Type 2.

Duration of immunity for BRSV, PI3, C. fetus and Leptospira spp. has not been established. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.

Respiratory and reproductive efficacy and duration of immunity has been demonstrated against disease caused by the BVD Type 1b strain. This product has been shown to be effective against urinary shedding of L. hardjo organisms.

SAFETY: Safe for use in pregnant heifers and cows or calves nursing pregnant cows provided the cows and heifers in the herd are vaccinated prior to breeding, within the previous 12 months, with any of the modified live IBR and BVD containing vaccine(s) in this product line.

MIXING DIRECTIONS: Rehydrate freeze dried vial of BOVILIS^® Vista^® 5 CFP with accompanying vial of BOVILIS^® VL5. Mix reconstituted vial well.

DOSAGE AND ROUTE: Shake well and administer a single 2 mL dose aseptically by subcutaneous route 14-60 days prior to breeding. Historically, annual revaccination with this product has been recommended. The need for this booster has not been established. For advice on revaccination frequency, contact your veterinarian.

Mixing Instructions (for 100 mL/50 doses format)

CAUTION: THE TRANSFER NEEDLE, INCLUDED IN THE CARTON PACKAGING (50 DOSES), IS SHARP AND MAY CAUSE INJURY TO SELF OR ANIMALS IF NOT HANDLED OR DISPOSED OF PROPERLY.

1. Insert the transfer needle fully into the small vial of dehydrated vaccine to release the vacuum.

2. Insert the other end of the transfer needle fully into the large vial of sterile diluent.

3. Squeeze enough diluent from the large bottle into the smaller vial to rehydrate the vaccine.

4. With the two bottles still attached, swirl the small vial gently until the vaccine is mixed.

5. With the small vial upside down, squeeze the large bottle several times to draw the mixed vaccine into the large bottle.

6. Separate the bottles and remove the vaccine label from the small vial and apply it to the large bottle for proper identification.

CAUTIONS: Store at 2 to 8°C (35 to 46°F). Fetal health risks associated with the vaccination of pregnant animals with this vaccine cannot be unequivocally determined during clinical trials conducted for licensure. Appropriate strategies to address the risks associated with vaccine use in pregnant animals should be discussed with a veterinarian.

Do not freeze. Use entire contents when first opened. Do not use chemical disinfectants to sterilize syringes or needles. Do not mix with other products, except as specified on the label. Inactivate unused contents before disposal. Do not vaccinate within 21 days of slaughter. If allergic reaction occurs, treat with epinephrine. Contains penicillin, streptomycin and thimerosal as preservatives. In case of human exposure, contact a physician.

FOR ANIMAL USE ONLY

Intervet Inc. d/b/a Merck Animal Health, Omaha, NE 68103, USA

VLN 165A/PCN 44B1.20

For patent information:

http://www.merck.com/product/patent/home.html

1 866 683-7838

			Code
20 mL	10 Doses	2 mL per dose	105397	711895 R1
100 mL	50 Doses		107197	799854 R2

CPN: 1208204.5